source
- FDA releases new guidances on adhesive performance and skin irritation studies for transdermal generic drugsThe U.S. Food and Drug Administration has issued two new guidances that address transdermal or topical delivery systems for generic drugs. One is a final guidance that outlines how to assess adhesi…
- Amgen discloses cybersecurity breach affecting patient dataAmgen reported a cybersecurity incident that resulted in the exfiltration of protected patient health information and other proprietary data stored in cloud services managed by third‑party provider…